Botulism as a Potential Agent of Bioterrorism

  • Thomas P. Bleck
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)


Botulinum Toxin Cervical Dystonia Tetanus Toxin Clostridium Botulinum Biological Weapon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahn-Yoon, S., DeCory, T.R., and Durst, R.A. (2004). Ganglioside-liposome immunoassay for the detection of botulinum toxin. Anal. Bioanal. Chem. 378:68–75.PubMedCrossRefGoogle Scholar
  2. Arnon, S.S., Schechter, R., Inglesby, T.V., Henderson, D.A., Bartlett, S.G., Ascher, M.S., Eitzen, E., Hauer, J., Layton, M., Lillibridge, S., Osterholm, M.T., O’Toole, T., Parker, G., Perl, T.M., Russell, P.K., Swerdlow, D.L., and Tonat, K, for the Working Group on Civilian Biodefence. (2001). Botulinum toxin as a biological weapon: medical and public health management. J.A.M.A. 285:1059–1070.PubMedGoogle Scholar
  3. Barrett, D.H. (1991). Endemic food-borne botulism: clinical experience, 1973–1986. Alaska. Med. 33:101–108.PubMedGoogle Scholar
  4. Black, R.E., and Gunn, R.A. (1980). Hypersensitivity reactions associated with botulinal antitoxin. Am. J. Med. 69:567–70.PubMedCrossRefGoogle Scholar
  5. Buchman, A.S., Comella, C.L., Stebbins, G.T., Tanner, C.M., and Goetz, C.G. (1993). Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin. Neuropharmacol. 16:205–10.PubMedGoogle Scholar
  6. Centers for Disease Control and Prevention. (1998). Botulism in the United States 1899–1996. In: Handbook for epidemiologists, clinicians, and laboratory workers. Centers for Disease Control and Prevention, Atlanta, Ga.Google Scholar
  7. Centers for Disease Control and Prevention. (1999). The history of bioterrorism. [Video]. Available at Scholar
  8. Cherington, M. (1990). Botulism. Semin. Neurol. 10:27–31.PubMedCrossRefGoogle Scholar
  9. Cherington, M. (1982). Electrophysiologic methods as an aid in diagnosis of botulism. A review. Muscle. Nerve. 6:528–529.Google Scholar
  10. Chia, J.K., Clark, J.B., Ryan, C.A., and Pollack, M.(1986). Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N. Engl. J. Med. 315:239–241.PubMedCrossRefGoogle Scholar
  11. Cohen, F.L., Hardin, S.B., Nehring, W., Keough, M.A., Laurenti, S., McNabb, J., Platis, C., and Weber, C. (1998). Physical and psychosocial health status 3 years after catastrophic illness-botulism. Issues Mental Health Nurs. 9:387–398.Google Scholar
  12. Colerbatch, J.G., Wolff, A.H., Gilbert, R.J., Mathias, C.J., Smith, S.E., Hirsch, N., and Wiles, C.M. (1989). Slow recovery from severe foodborne botulism. Lancet. 2:1216–1217.CrossRefGoogle Scholar
  13. Comella, C.L., Tanner, C.M., DeFoor-Hill, L., and Smith, C. (1992). Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findings. Neurology 42(7):1307–1310.PubMedGoogle Scholar
  14. Cornblath, D.R., Sladky, J.T., and Sumner A.J. (1983). Clinical electrophysiology of infantile botulism. Muscle. Nerve. 6:448–452.PubMedCrossRefGoogle Scholar
  15. Davis, J.B., Mattman, L.H., and Wiley, M. (1951). Clostridium botulinum in a fatal wound infection. J.A.M.A. 146:646–648.Google Scholar
  16. Dowell, V.R. Jr., McCroskey, L.M., Hatheway, C.L., Lombard, G.L., Hughes, J.M., and Merson, M.H. (1977). Coproexamination for botulinal toxin and Clostridium botulinum. A new procedure for laboratory diagnosis of botulism. J.A.M.A. 238:1829–1832.PubMedGoogle Scholar
  17. Dunbar, E.M. (1990). Botulism. J. Infect. 20:1–3.PubMedCrossRefGoogle Scholar
  18. Edell, T.A., Sullivan, C.P., Jr., Osborn, K.M., Gambin, J.P., and Brenman, R.D. (1983). Wound botulism associated with a positive tensilon test. West. J. Med. 139:218–219.PubMedGoogle Scholar
  19. Elston, H.R., Wang, M., and Loo, L.K. (1991). Arm abscesses caused by Clostridium botulinum. J. Clin. Microbiol. 29:2678–2379.PubMedGoogle Scholar
  20. Frankovich, T.L., and Arnon, S.S. (1991). Clinical trial of botulism immune globulin for infant botulism. West. J. Med. 154:103.PubMedGoogle Scholar
  21. Franz, D.R., Pitt, L.M., Clayton, M.A., Hanes, M.A., and Rose, K.J. (1993). Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism. In: Das Gupta, B.R. (ed.), Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects. Plenum, New York, pp. 473–476.Google Scholar
  22. Friedman, D.I., Fortanasce, V.N., and Sadun, A.A. (1990). Tonic pupils as a result of botulism. Am. J. Ophthalmol. 109:236–237.PubMedGoogle Scholar
  23. Glauser, T.A., Maquire, H.C., and Sladky, J.T. (1990). Relapse of infant botulism. Ann. Neurol. 28:187–189.PubMedCrossRefGoogle Scholar
  24. Gutmann, L., and Pratt, L. (1976). Pathophysiologic aspects of human botulism. Arch. Neurol. 33:175–179.PubMedGoogle Scholar
  25. Hatheway, C.L. (1989). Bacterial sources of clostridial neurotoxins. In: Simpson, L.L. (ed.), Botulinum Neurotoxin and Tetanus Toxin. Academic Press, San Diego, pp. 4–25.Google Scholar
  26. Holzer, V.E. (1962). Botulismus durch inhalation. Med. Klin. 57:1735–1738.PubMedGoogle Scholar
  27. Hughes, J.M., Blumenthal, J.R., Merson, M.H., Lombard, G.L., Dowell, V.R. Jr., and Gangarosa, E.J. (1981). Clinical features of types A and B foodborne botulism. Ann. Intern. Med. 95:442–445.PubMedGoogle Scholar
  28. Kaplan, J.E., Davis, L.E., Narayan, V., Koster, J., and Katzenstein, D. (1979). Botulism, type A, and treatment with guanidine. Ann. Neurol. 6:69–71.PubMedCrossRefGoogle Scholar
  29. Kerner, J. (1928). Neue Beobachtungen über die in Würtemburg so haüfig vorfallen Vergiftung durch den Genuss gerauchter Würst. Tubingen, 1820. Quoted in: Damon, S.R. (ed.), Food Infections and Food Intoxications. Williams & Wilkins, Baltimore, p. 67.Google Scholar
  30. Kortepeter, M.G., Cieslak, T.J., and Eitzen, E.M. (2001). Bioterrorism. J. Environ. Health 63:21–24.PubMedGoogle Scholar
  31. Kudrow, D.B., Henry, D.A., Haake, D.A., Marshall, G., and Mathiesen, G.E. (1988). Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse. Ann. Intern. Med. 109:984–985.PubMedGoogle Scholar
  32. Landman, G. (1984). Ueber die Ursache der Darmstadter Bohnen Vergiftung. Hyg. Rundsch. 14:449–452.Google Scholar
  33. Lifton, R.J. (2000). Destroying the World to Save It. Henry Holt and Company, New York, pp. 39, 186–188.Google Scholar
  34. Liu, W., Montana, V., Chapman, E.R., Mohideen, U., and Parpura, V. (2003). Botulinum toxin type B micromechanosensor. Proc. Natl. Acad. Sci. U.S.A. 100:13621–13625.PubMedCrossRefGoogle Scholar
  35. Middlebrook, J.L., and Franz, D.R. (1997). Botulinum toxins. In: Sidell, F.R., Takafuji, E.T., and Franz, D.R. (eds), Medical Aspects of Chemical and Biological Warfare. Office of the Surgeon General, Washington, D.C. Available online at: Google Scholar
  36. Midura, T.F., and Arnon, S.S. (1976). Infant botulism: identification of Clostridium botulinum and its toxin in faeces. Lancet. 2:934–936.PubMedCrossRefGoogle Scholar
  37. M’ikantha, N.M., Southwell, B., and Lautenbach, E. (2003). Automated laboratory reporting of infectious diseases in a climate of bioterrorism. Emerg. Infect. Dis. 9:1053–1057.PubMedGoogle Scholar
  38. Notermans, S., and Nagel, J. (1989). Assays for botulinum and tetanus toxins. In: Simpson, L.L. (ed.), Botulinum Neurotoxin and Tetanus Toxin. Academic Press, San Diego, pp. 319–331.Google Scholar
  39. Notermans, S.H.W., Wokke, J.H.J., and van. den. Berg., L.H. (1982). Botulism and Guillain-Barré syndrome. Lancet. 340:303.CrossRefGoogle Scholar
  40. Oguma, K., Yokota, K., Hayashi, S., Takeshi, K., Kumagai, M., Itosh, N., and Chiba S. (1990). Infant botulism due to Clostridium botulinum type C toxin. Lancet. 336:1449–1450.PubMedCrossRefGoogle Scholar
  41. Oken, A, Barnes, S., Rock, P., and Maxwell, L. (1992). Upper airway obstruction and infant botulism. Anesth. Analg. 75:136–138.PubMedGoogle Scholar
  42. Peruski, A.H., Johnson, L.H. 3rd, and Peruski, L.F. Jr. (2002). Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J. Immunol. Methods. 263:35–41.PubMedCrossRefGoogle Scholar
  43. Schreiner, M.S., Field, E., and Ruddy, R. (1991). Infant botulism: a review of 12 years experience at the Children’s Hospital of Philadelphia. Pediatrics. 87:159–165.PubMedGoogle Scholar
  44. Smith, L.D.S. (1977). Botulism: The Organism, Its Toxins, The Disease. CC Thomas, Springfield, 236 pp.Google Scholar
  45. Tacket, C.O., and Rogawski, M.A. (1989). Botulism. In: Simpson, L.L. (ed.), Botulism Neurotoxin and Tetanus Toxin, Academic Press, San Diego, pp. 351–378.Google Scholar
  46. Terranova, W., Breman, J.G., Locey, R.P., and Speck, S. (1978). Botulism type B: epidemiologic aspects of an extensive outbreak. Am. J. Epidemiol. 108:150–156.PubMedGoogle Scholar
  47. Terranova, W., Palumbo, J.N., and Berman, J.G. (1979). Ocular findings in botulism type B. J.A.M.A. 241:475–477.PubMedGoogle Scholar
  48. Todd, E.C.D. (1989). Costs of acute bacterial foodborne disease in Canada and the United States. Int. J. Food Microbiol. 9:313–326.PubMedCrossRefGoogle Scholar
  49. van Ermengen, E. (1897). Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus. Zeitschrift für Hygiene und Infektionskrankheiten 26:1–256.CrossRefGoogle Scholar
  50. Vita, G., Girlanda. P., Puglisi, R.M., Marbello, L., and Messina, C. (1987). Cardiovascular-reflex testing and single-fiber electromyography in botulism. A longitudinal study. Arch. Neurol. 44:202–206.PubMedGoogle Scholar
  51. Wackers, G.L. (1994). Modern anaesthesiological principles for bulbar polio: manual IPPR in the 1952 polio-epidemic in Copenhagen. Acta. Anaesthesiol. Scand. 38:420–431.PubMedGoogle Scholar
  52. Wilcox, P.G., Morrison, N.J., and Pardy, R.L. (1990), Recovery of the ventilatory and upper airway muscles and exercise performance after type A botulism. Chest. 98:620–626.PubMedGoogle Scholar
  53. Williams, P., and Wallace, D. (1989). Unit 731: Japan’s Secret Biological Warfare in World War II. The Free Press, New York, pp. 27–28.Google Scholar
  54. Woodruff, B.A., Griffin, P.M., McCroskey, L.M., Smart, J.F., Wainwright, R.B., Bryant, R.G., Hutwagner, L.C., and Hatheway, C.L. (1992). Clinical and laboratory comparison of botulism from toxin type A, B, and E in the United States, 1975–1988. J. Infect. Dis. 166:1281–1286.PubMedGoogle Scholar
  55. Young, J.H. (1976). Botulism and the ripe olive scare of 1891–1920. Bull. History Med. 50:372–391.Google Scholar
  56. Zilinskas, R.A. (1997). Iraq’s biological weapons. The past as future? J.A.M.A. 278:418–424.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Thomas P. Bleck
    • 1
  1. 1.Neuroscience Intensive Care UnitNeurological Surgery and Internal MedicineCharlottesville

Personalised recommendations